HCPCS M0221 Code. Tixagev and cilgav inj hm


Table of content for "Tixagev and cilgav inj hm" (HCPCS M0221)

General information on the “M0221” code

HCPCS Code: M0221
Long Description: Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
Short Description: Tixagev and cilgav inj hm

Original information is taken from M0221 page

Pricing indicators

Pricing Indicator Code 1: 54 – Vaccinations
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology

Certification and additional reference information

Coverage

Coverage: C – Carrier judgment

Type of service


Berenson-Eggers Type of Service (BETOS): O1G – Immunizations/Vaccinations
Type Of Service 1: V – Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95

Misc information

Anesthesia Base Unit Quantity: 0
Code Added Date: 20211208
Code Effective Date: 20211208
Action Code: N – No maintenance for this code